Empagliflozin versus Sitagliptin as add-on dual therapy in Egyptian patients with type 2 diabetes inadequately controlled with Metformin: a 12-week randomized, open-label, parallel-group trial
Beni-Seuf University Journal of Basic and Applied Sciences /Beni-Suef University Journal of Basic and Applied Sciences